Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ruud Dings

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angiogenesis Inhibitors
25
2022
182
4.080
Why?
Proteins
17
2010
348
2.450
Why?
Neovascularization, Pathologic
17
2022
153
2.430
Why?
Calixarenes
7
2017
9
1.960
Why?
Melanoma, Experimental
6
2021
40
1.850
Why?
Galectin 1
8
2024
20
1.840
Why?
Antineoplastic Agents
14
2024
1176
1.580
Why?
Peptides
20
2017
221
1.380
Why?
Mice
47
2024
5673
1.290
Why?
Neoplasms
14
2024
1233
1.220
Why?
Animals
53
2024
13141
1.060
Why?
Endothelial Cells
10
2022
257
1.050
Why?
Lung Neoplasms
5
2024
601
1.050
Why?
Gold
7
2023
129
0.880
Why?
Ovarian Neoplasms
8
2008
450
0.880
Why?
Oxygen
6
2020
321
0.860
Why?
Cell Line, Tumor
18
2024
1390
0.810
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
154
0.780
Why?
Carcinoma, Squamous Cell
4
2019
330
0.750
Why?
Proto-Oncogene Proteins c-met
1
2021
19
0.740
Why?
Peptide Fragments
5
2013
207
0.720
Why?
Mammary Neoplasms, Experimental
6
2015
121
0.720
Why?
Radiation-Sensitizing Agents
4
2023
51
0.710
Why?
Head and Neck Neoplasms
3
2019
281
0.690
Why?
Carcinoma, Lewis Lung
1
2019
9
0.680
Why?
Molecular Targeted Therapy
2
2018
121
0.660
Why?
Protein Kinase Inhibitors
1
2021
205
0.650
Why?
Preservation, Biological
1
2018
8
0.640
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
75
0.640
Why?
Anti-Bacterial Agents
4
2019
744
0.630
Why?
Radiation Tolerance
5
2020
83
0.630
Why?
CD8-Positive T-Lymphocytes
1
2019
123
0.630
Why?
Galectins
1
2018
5
0.610
Why?
Metal Nanoparticles
4
2023
80
0.570
Why?
Hyperthermia, Induced
3
2019
116
0.560
Why?
Bacteria
1
2018
220
0.560
Why?
Mice, Nude
12
2019
252
0.550
Why?
Radiotherapy
5
2021
124
0.540
Why?
Xenograft Model Antitumor Assays
11
2020
212
0.520
Why?
Pseudomonas aeruginosa
2
2013
74
0.490
Why?
Combined Modality Therapy
11
2020
639
0.440
Why?
Benzofurans
2
2012
18
0.430
Why?
Cytotoxins
1
2013
15
0.430
Why?
Cell Proliferation
10
2024
987
0.420
Why?
Pseudomonas Infections
1
2013
50
0.410
Why?
Drug Design
4
2014
119
0.410
Why?
Oxidation-Reduction
3
2024
317
0.410
Why?
Endothelium, Vascular
8
2010
252
0.410
Why?
Carbohydrate Metabolism
1
2012
26
0.410
Why?
Humans
44
2024
50201
0.410
Why?
Neoplasms, Experimental
4
2020
111
0.400
Why?
Nanostructures
3
2023
45
0.400
Why?
Benzeneacetamides
2
2024
12
0.390
Why?
Glutaminase
2
2024
18
0.390
Why?
Bacteremia
1
2013
89
0.390
Why?
Sesquiterpenes
3
2010
88
0.380
Why?
Angiostatic Proteins
1
2011
1
0.370
Why?
Immunity, Cellular
1
2011
69
0.360
Why?
Cell Survival
8
2024
590
0.360
Why?
Molecular Mimicry
2
2007
38
0.360
Why?
Dendritic Cells
3
2021
133
0.350
Why?
Endothelium
4
2022
37
0.350
Why?
Carboplatin
3
2024
51
0.340
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2008
1000
0.330
Why?
Tumor Necrosis Factor-alpha
4
2019
388
0.330
Why?
Immunotherapy, Adoptive
1
2011
159
0.320
Why?
Cells, Cultured
8
2013
1587
0.320
Why?
Vascular Endothelial Growth Factor A
7
2022
183
0.320
Why?
Apoptosis
7
2024
1093
0.320
Why?
Intercellular Adhesion Molecule-1
5
2022
61
0.310
Why?
T-Lymphocytes
1
2011
329
0.310
Why?
Structure-Activity Relationship
6
2012
394
0.310
Why?
Polyethylene Glycols
3
2021
86
0.310
Why?
Mice, Inbred C57BL
8
2021
1782
0.300
Why?
Phototherapy
2
2019
42
0.300
Why?
Amino Acid Sequence
5
2012
576
0.290
Why?
Tumor Cells, Cultured
6
2019
462
0.290
Why?
Female
24
2020
26829
0.290
Why?
Drug Resistance, Neoplasm
2
2024
315
0.280
Why?
Magnetic Resonance Spectroscopy
5
2012
246
0.270
Why?
Blood Vessels
4
2015
71
0.270
Why?
Antibodies, Monoclonal
2
2007
459
0.270
Why?
Disease Models, Animal
7
2020
1419
0.250
Why?
Molecular Sequence Data
5
2012
795
0.250
Why?
Nanoparticles
2
2017
151
0.240
Why?
Cell Division
7
2010
293
0.230
Why?
Bystander Effect
1
2024
25
0.230
Why?
Human Umbilical Vein Endothelial Cells
3
2014
90
0.230
Why?
Cysteine
1
2024
50
0.230
Why?
Buthionine Sulfoximine
1
2024
13
0.230
Why?
Nanotubes
2
2021
27
0.230
Why?
Models, Molecular
4
2024
334
0.220
Why?
Thiadiazoles
2
2024
18
0.220
Why?
Flow Cytometry
2
2017
475
0.200
Why?
Cisplatin
1
2024
275
0.200
Why?
Alanine
3
2012
41
0.200
Why?
Carcinoma, Renal Cell
1
2022
101
0.190
Why?
Protein Binding
3
2012
655
0.190
Why?
Binding Sites
2
2012
375
0.190
Why?
Optical Imaging
2
2020
23
0.190
Why?
Silver
2
2021
48
0.190
Why?
Kidney Neoplasms
1
2022
173
0.190
Why?
Polyurethanes
1
2021
10
0.190
Why?
Radiation
1
2020
15
0.180
Why?
Forkhead Transcription Factors
1
2021
110
0.180
Why?
Materials Testing
1
2021
56
0.180
Why?
Spectrum Analysis
1
2020
71
0.180
Why?
Biocompatible Materials
1
2021
68
0.180
Why?
Mice, Inbred BALB C
5
2020
296
0.170
Why?
CD4-Positive T-Lymphocytes
1
2021
157
0.170
Why?
Mice, Knockout
3
2012
840
0.170
Why?
Neoplasm Transplantation
5
2007
84
0.170
Why?
Disease Progression
3
2019
821
0.170
Why?
Oxygen Consumption
1
2020
189
0.170
Why?
Lactose
2
2024
9
0.170
Why?
Specimen Handling
1
2018
54
0.160
Why?
Immunotherapy
1
2020
235
0.160
Why?
Spectrum Analysis, Raman
1
2019
55
0.160
Why?
Drug Delivery Systems
2
2019
144
0.150
Why?
Biological Assay
1
2018
46
0.150
Why?
Time Factors
6
2017
2909
0.150
Why?
Feces
1
2018
131
0.150
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2018
55
0.150
Why?
Indazoles
1
2018
44
0.150
Why?
Carbohydrates
1
2018
40
0.150
Why?
Temperature
1
2018
165
0.150
Why?
Cell Hypoxia
4
2015
82
0.150
Why?
Histocompatibility Antigens Class II
1
2017
37
0.140
Why?
Tumor Microenvironment
1
2019
222
0.140
Why?
Male
9
2019
25572
0.140
Why?
Drug Therapy, Combination
1
2018
382
0.140
Why?
Neoplastic Cells, Circulating
1
2017
74
0.140
Why?
Epithelial Cells
1
2018
210
0.140
Why?
Cell Line
4
2017
1010
0.130
Why?
Lipopolysaccharides
2
2008
196
0.130
Why?
Umbilical Veins
4
2010
23
0.130
Why?
Enzyme Inhibitors
1
2018
378
0.130
Why?
Leukocytes
3
2006
69
0.120
Why?
Molecular Imaging
1
2015
54
0.120
Why?
Azides
1
2014
10
0.120
Why?
Fluorine Radioisotopes
1
2014
24
0.120
Why?
Tumor Burden
2
2013
131
0.120
Why?
Cell Transformation, Neoplastic
2
2007
181
0.120
Why?
Immunohistochemistry
5
2020
973
0.120
Why?
Interleukin-2
2
2021
70
0.120
Why?
Drug Synergism
2
2005
152
0.110
Why?
Cell Adhesion
3
2006
155
0.110
Why?
Piperacillin
1
2013
23
0.110
Why?
Peptidomimetics
1
2012
2
0.110
Why?
Penicillanic Acid
1
2013
20
0.110
Why?
Agglutination Tests
1
2012
5
0.100
Why?
Allosteric Regulation
1
2012
13
0.100
Why?
Inflammation Mediators
1
2013
110
0.100
Why?
Cell Cycle
1
2013
226
0.100
Why?
Antimicrobial Cationic Peptides
2
2008
28
0.090
Why?
Up-Regulation
2
2011
446
0.090
Why?
Metformin
1
2012
63
0.090
Why?
Partial Pressure
1
2011
14
0.090
Why?
Neoplastic Stem Cells
1
2012
100
0.090
Why?
Fibroblasts
1
2013
352
0.090
Why?
Glutamine
2
2024
173
0.090
Why?
Adjuvants, Immunologic
1
2011
51
0.090
Why?
Chemotherapy, Adjuvant
1
2011
121
0.090
Why?
Cell Movement
4
2006
245
0.090
Why?
Spiro Compounds
1
2010
8
0.090
Why?
Cytokines
1
2013
607
0.080
Why?
Lignans
1
2008
6
0.080
Why?
Salmonella typhimurium
1
2008
48
0.080
Why?
Amino Acid Substitution
1
2008
81
0.080
Why?
Klebsiella pneumoniae
1
2008
20
0.080
Why?
Furans
1
2008
26
0.080
Why?
Surface Properties
1
2007
72
0.070
Why?
Escherichia coli
1
2008
191
0.070
Why?
Angiostatins
2
2006
2
0.070
Why?
Vascular Neoplasms
1
2007
17
0.070
Why?
Endotoxins
1
2006
31
0.070
Why?
Concept Formation
1
2006
12
0.070
Why?
Gram-Negative Bacteria
1
2006
35
0.070
Why?
Protein Structure, Secondary
2
2003
71
0.070
Why?
Interleukin-8
1
2006
86
0.070
Why?
Genes, Synthetic
1
2005
1
0.060
Why?
Protein Engineering
1
2005
18
0.060
Why?
Antibodies, Monoclonal, Humanized
1
2007
224
0.060
Why?
Cloning, Molecular
1
2005
188
0.060
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
137
0.060
Why?
Angiogenic Proteins
1
2004
6
0.060
Why?
Dietary Supplements
1
2008
445
0.060
Why?
Colonic Neoplasms
1
2006
158
0.060
Why?
Histones
1
2006
296
0.060
Why?
Protein Unfolding
1
2024
6
0.060
Why?
Disulfides
1
2024
16
0.060
Why?
Diphtheria Toxin
1
2004
4
0.060
Why?
Feasibility Studies
1
2006
383
0.060
Why?
Mutagenesis, Site-Directed
1
2024
96
0.060
Why?
Protein Folding
1
2024
48
0.060
Why?
Mammary Neoplasms, Animal
1
2004
35
0.060
Why?
Osmosis
1
2003
5
0.050
Why?
Infusion Pumps
1
2003
13
0.050
Why?
Circular Dichroism
1
2003
41
0.050
Why?
Plasminogen
1
2003
2
0.050
Why?
Dose-Response Relationship, Drug
2
2004
1356
0.050
Why?
Serum Albumin
1
2003
58
0.050
Why?
Extracellular Matrix
1
2003
108
0.050
Why?
Immune Tolerance
1
2022
84
0.050
Why?
Gene Expression Regulation, Neoplastic
4
2008
824
0.050
Why?
Reactive Oxygen Species
1
2024
406
0.050
Why?
Endostatins
3
2007
4
0.050
Why?
Neoplasm Invasiveness
1
2022
269
0.050
Why?
Immunity
1
2021
34
0.050
Why?
Immune System
1
2021
43
0.050
Why?
Ethers
1
2021
8
0.050
Why?
Melanoma
1
2004
281
0.050
Why?
Regenerative Medicine
1
2021
10
0.050
Why?
Tissue Scaffolds
1
2021
36
0.040
Why?
Angiogenesis Inducing Agents
1
2000
8
0.040
Why?
Dose-Response Relationship, Radiation
1
2020
184
0.040
Why?
Tissue Engineering
1
2021
67
0.040
Why?
Bone Marrow Cells
1
2021
190
0.040
Why?
Adenocarcinoma
1
2004
402
0.040
Why?
Mice, Inbred C3H
2
2012
84
0.040
Why?
Gene Expression Profiling
1
2004
1029
0.040
Why?
Skin Neoplasms
1
2004
487
0.040
Why?
Flavin-Adenine Dinucleotide
1
2018
4
0.040
Why?
Inflammation
1
2022
608
0.040
Why?
NAD
1
2018
42
0.040
Why?
Microcirculation
2
2010
72
0.040
Why?
Guidelines as Topic
1
2018
110
0.040
Why?
Glutathione
1
2019
297
0.040
Why?
Microscopy, Fluorescence
1
2018
164
0.040
Why?
Phagocytosis
1
2017
49
0.040
Why?
Glycolysis
1
2017
68
0.030
Why?
Transplantation, Heterologous
2
2008
75
0.030
Why?
Clonal Anergy
2
2006
13
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Nitroimidazoles
1
2015
15
0.030
Why?
Microbubbles
1
2015
25
0.030
Why?
Cell Count
1
2015
147
0.030
Why?
Stromal Cells
1
2015
72
0.030
Why?
Pressure
1
2015
105
0.030
Why?
Paclitaxel
2
2006
83
0.030
Why?
Down-Regulation
2
2006
342
0.030
Why?
Drug Evaluation, Preclinical
1
2015
145
0.030
Why?
Radiochemistry
1
2014
1
0.030
Why?
Cycloaddition Reaction
1
2014
1
0.030
Why?
Click Chemistry
1
2014
3
0.030
Why?
Random Allocation
1
2015
288
0.030
Why?
Recombinant Proteins
2
2006
480
0.030
Why?
Radiotherapy Dosage
1
2015
247
0.030
Why?
Cell Differentiation
1
2017
648
0.030
Why?
Imaging, Three-Dimensional
1
2015
152
0.030
Why?
Contrast Media
1
2015
186
0.030
Why?
Molecular Structure
1
2014
293
0.030
Why?
Ultrasonography
1
2015
438
0.030
Why?
Chromatography, High Pressure Liquid
1
2014
326
0.030
Why?
Ribosomal Protein S6 Kinases
1
2012
8
0.030
Why?
Adenylate Kinase
1
2012
9
0.030
Why?
TOR Serine-Threonine Kinases
1
2012
77
0.020
Why?
Rats
2
2008
3277
0.020
Why?
Radiometry
1
2012
123
0.020
Why?
4-Butyrolactone
1
2008
5
0.020
Why?
Butylene Glycols
1
2008
14
0.020
Why?
Phytoestrogens
1
2008
22
0.020
Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
50
0.020
Why?
Ovariectomy
1
2008
113
0.020
Why?
Receptors, Progesterone
1
2008
63
0.020
Why?
Estrogen Receptor beta
1
2008
54
0.020
Why?
Estrogen Receptor alpha
1
2008
86
0.020
Why?
Cell Growth Processes
1
2007
22
0.020
Why?
Carcinogens
1
2008
197
0.020
Why?
Horseshoe Crabs
1
2006
3
0.020
Why?
Blood Bactericidal Activity
1
2006
4
0.020
Why?
Lipid A
1
2006
4
0.020
Why?
Polymyxin B
1
2006
5
0.020
Why?
Neutralization Tests
1
2006
24
0.020
Why?
Cytidine
1
2006
5
0.020
Why?
Pyrroles
1
2007
68
0.020
Why?
DNA Modification Methylases
1
2006
28
0.020
Why?
Endotoxemia
1
2006
33
0.020
Why?
Acetylation
1
2006
93
0.020
Why?
Blood Proteins
1
2006
77
0.020
Why?
Methylation
1
2006
118
0.020
Why?
Vimentin
1
2006
32
0.020
Why?
Chick Embryo
1
2006
83
0.020
Why?
Nucleic Acid Hybridization
1
2006
55
0.020
Why?
Gene Silencing
1
2006
114
0.020
Why?
Cyclohexanes
1
2006
4
0.020
Why?
Zebrafish
1
2006
54
0.020
Why?
Transfection
1
2007
354
0.020
Why?
Histone Deacetylase Inhibitors
1
2006
57
0.020
Why?
Histone Deacetylases
1
2006
50
0.020
Why?
Vascular Cell Adhesion Molecule-1
1
2006
36
0.020
Why?
Pichia
1
2005
8
0.020
Why?
Gene Transfer Techniques
1
2005
38
0.020
Why?
Cyclophosphamide
1
2006
164
0.020
Why?
Neovascularization, Physiologic
1
2005
68
0.020
Why?
Sequence Homology, Nucleic Acid
1
2004
49
0.010
Why?
Membrane Proteins
1
2006
347
0.010
Why?
Indoles
1
2007
273
0.010
Why?
Treatment Outcome
1
2014
5203
0.010
Why?
Necrosis
1
2004
175
0.010
Why?
Antibodies
1
2004
151
0.010
Why?
Skin
1
2007
416
0.010
Why?
In Situ Nick-End Labeling
1
2003
52
0.010
Why?
Base Sequence
1
2004
653
0.010
Why?
Sequence Homology, Amino Acid
1
2003
145
0.010
Why?
Epigenesis, Genetic
1
2006
371
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
579
0.010
Why?
Mice, Transgenic
1
2004
542
0.010
Why?
RNA, Messenger
1
2004
1097
0.010
Why?
Endothelial Growth Factors
1
2000
9
0.010
Why?
Vascular Endothelial Growth Factors
1
2000
13
0.010
Why?
Fibroblast Growth Factor 2
1
2000
34
0.010
Why?
Lymphokines
1
2000
20
0.010
Why?
Scrotum
1
2000
30
0.010
Why?
Interleukin-1
1
2000
106
0.010
Why?
Models, Biological
1
2002
722
0.010
Why?
Breast Neoplasms
1
2004
1187
0.010
Why?
Dings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description